STOKE THERAPEUT.DL-001

Healthcare · EUR · F

0GT

Price

€25.111

-1.40%

Cap

€2.05B

Earnings

—

30d Trend

-15.6%

0GT

Loading chart data...

0 days · % change from startPowered by Brain47

BRAIN47 SIGNAL

MODERATE

Risk Level80

Quality46

Momentum72

Technical51

Fundamentals50

Raw weighted: 51×Macro 0.99 (−1%)=50

RISK

80/100

90d Volatility

54.0%High

ATR %

5.2%High daily moves

Max Drawdown (1Y)

-37.2%Volatile

QUALITY

46/100

ROE (avg)

-2.0%Negative

Piotroski F-Score

5/9Average

Accruals

-12.5%Cash earnings

MOMENTUM

72/100

12-1M Momentum

+239.2%Strong uptrend

6-1M Momentum

+7.4%Positive

1M Return

-5.6%Recent pullback

Relative Strength

+0.3% vs sectorIn-line

TECHNICAL

51/100

RSI (14)

47.3Neutral

Price vs SMA200

+5.5%Bullish trend

MACD

-0.02Bearish momentum

Bollinger Band

46%Mid-range

SMA Cross

Death CrossDeath Cross

Trend Quality (KER)

0.145Noisy/choppy

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 80%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months41

3-12 months ★52

1-5+ years49

Medium-term outlook is neutral — no clear directional thesis

BRAIN47'S ASSESSMENT

I rate STOKE THERAPEUT.DL-001 at 50/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 72/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

DETAILED ANALYSIS

Medium-term outlook is neutral — no clear directional thesis. Momentum (72) and Technical (51) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 50/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.